Mylan Recent News
Mylan's CEO Showed 'Very Little Empathy,' Bill George Says
Mylan Investors Should Be Asking Where (And Who) Robert Coury Is
MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says
Mylan CEO: The Healthcare System Is Broken
Mylan Cuts EpiPen Costs By Up To 50% Via Coupon
Have You Heard About This Generic EpiPen Maker?
Generic Drugs In The Earnings Spotlight: Mylan And Valeant Pharmaceuticals
Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda
Barron's Picks & Pans: Martin Marietta Materials, Deutsche Bank, Mylan And More
Shares Of Mylan Slightly Higher Following Launch Of Generic Drug
Mylan-Perrigo Buyout Offer: What's Next?
Theravance Just Lost Its Catalyst
Is Mylan's FDA Warning Letter Worth Worrying About?
Report: Mylan Could See Sweetened Bid From Teva Pharmaceutical
What's Gabelli Saying About Teva Now?
And The Winner From The Mylan-Perrigo Merger Is... Teva?
JPMorgan Says Mylan Has 3 Paths To Upside
S&P 500 Falls To Two-Month Low, Dow Drifts Further Away From The 17,000 Mark
5 Drug Companies Profiting From Generics
Dow Sets New Intraday High; Citigroup Impresses With Earnings
Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More
Market Wrap For April 4: Dow Suffers Triple Digit Point Loss, Nasdaq Continues To Underperform
Pfizer's Blockbuster Drug Celebrex To Lose Patent Protection